Key facts
- It has raised $230K; the latest was Seed Round ($180K) in Jun 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for AI Pathology
- ·The full record, as it builds
Funding rounds
No funding rounds for AI Pathology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AI Pathology
Developer of AI-powered health technologies designed to support early detection and care prioritization in dermatology. The company analyzes skin lesions and post-surgical conditions using intelligent triage protocols, enabling healthcare providers to make diagnoses, reduce system costs, and improve patient outcomes.
- Sector
- Healthcare
- HQ
- Sao Paulo, Brazil
- Founded
- 2023
- Employees
- 5
- Website
- aipathology.com.br/
- Ownership
- Privately Held (backing)
AI Pathology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AI Pathology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AI Pathology in its N-PORT filings yet. We sweep new filings monthly.